Inventor

ROSENTHAL ARNON

US121 patents

⚠️ This page may combine multiple inventors who share the name “ROSENTHAL ARNON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ROSENTHAL ARNON

GENENTECH INC

Antibodies to neurotrophic factor-4 (NT-4)

Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells

Fused

Neurotrophic factor (NT-4)

Neurotrophic factor

Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production

Neurturin receptor

Neurturin receptor

Antibodies to vertebrate smoothened proteins

Anti-neurturin receptor-A antibody compositions comprising cytokines or neurotrophic factors

Polynucleotides encoding GFRα3

Neurotrophic factor

Methods using a novel neurotrophic factor, NT-4

LABRYS BIOLOG INC

Methods of treating vasomotor symptoms using antibodies

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Methods of using anti-CGRP antagonist antibodies

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Methods of using anti-CGRP antagonist antibodies

ALECTOR LLC

Anti-sortilin antibodies and methods of use thereof

Methods of screening for sortilin binding antagonists

Anti-TREM2 antibodies and methods of use thereof

Methods of increasing progranulin levels using anti-Sortilin antibodies

Isolated nucleic acids encoding anti-sortilin antibodies

Anti-CD33 antibodies and methods of use thereof

Anti-sortilin antibodies and methods of use thereof

Anti-sortilin antibodies and methods of use thereof

ANNEXON INC

Anti-complement factor C1q antibodies and uses thereof

Anti-complement factor C1Q antibodies and uses thereof

Anti-complement factor C1q antibodies and uses thereof

Humanized anti-complement factor C1Q antibodies

Anti-complement factor C1q antibodies and uses thereof

Anti-complement factor C1q Fab fragments and uses thereof

TEVA PHARMACEUTICALS INT GMBH

Antagonist antibodies directed against calcitonin gene-related peptide

Antagonist antibodies directed against calcitonin gene-related peptide

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

PFIZER

Anti-NGF antibodies and methods using same

Anti-NGF antibodies and methods using same

Anti-NGF antibodies and methods using same

RINAT NEUROSCIENCE CORP

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Antibodies directed against amyloid-beta peptide and nucleic acids encoding same

Antibodies directed against amyloid-beta peptide

ZELLER JOERG

Methods of using anti-CGRP antagonist antibodies

PONS JAUME

Anti-NGF antibodies and methods using same

ROSENTHAL ARNON

Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same

MILLS IAN WILLIAM

Treatment of interstitial cystitis